ORLANDO, Fla., May 11, 2026 (GLOBE NEWSWIRE)-- NexTel Medical Corp (f/k/a Exousia Pro, Inc.) (OTCPK: MAJI), a clinical-stage biotechnology leader specializing in proprietary exosome-based delivery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results